HAEMONETICS CORP

# Haemonetics Corporation

Haemonetics is a medical technology company that develops and markets automated systems and related consumables for blood management, plasma collection, and surgical applications across hospital and clinical settings globally. The company's product portfolio spans multiple therapeutic areas, including plasmapheresis equipment, donor management software platforms, hemostasis monitoring systems, and vascular closure devices. Its offerings address procedural needs in electrophysiology, critical care, neurocritical care, trauma, and various surgical specialties.

The company operates through distinct business segments focused on plasma collection technologies, hospital-based diagnostic and monitoring systems, and interventional medical devices. Its plasma division supplies the NexSys PCS and PCS2 plasmapheresis systems alongside donor management software. The hospital segment provides the TEG hemostasis analyzer platform and Cell Saver Elite+ autologous blood recovery systems. In interventional applications, Haemonetics offers sensor-guided guidewires and catheter-based vascular closure products for procedures including transcatheter aortic valve replacement and coronary intervention.

Haemonetics operates with approximately 3,000 full-time employees and maintains headquarters in Boston, Massachusetts. The company distributes its products through a combination of direct sales operations, independent distributors, and clinical specialists across the United States and international markets. Founded in 1971, the company maintains a presence across developed healthcare systems globally.